![IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases](https://www.mdpi.com/ijms/ijms-24-09531/article_deploy/html/images/ijms-24-09531-g001.png)
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//16998855/0000005500000001/v1_202201010708/S1699885521000714/v1_202201010708/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNdV4B9vwZQjgKcZv3MP4Cdswkg7sYkbYTjRzbcc3AKzBua3jDLxcnPVMKe3llf3NF39Tx2DCDiAd9FKlpHGMUfOk13/aAMSrydD4UDQHfdS44LpMGEJOdEX4Y4KamsbHTQYz05t6Cwc4ixJTJ2EBMXBlM+kBUvZLGFAKPRurwLY5FwqgBFs2GddU9QOR46I1SxBLMlgxMl/54F6CngSqUm8QmjrCuZqu+JxTp8a+suk7FQSCqIpYLFrjdhjzDgiAzs=)
SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología
![Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-81321-5/MediaObjects/41598_2021_81321_Fig7_HTML.png)
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
![Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust](https://mft.nhs.uk/app/uploads/2023/01/Myeloma-diagnostic-tool.png)
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
![Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016 Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016](https://journals.sagepub.com/cms/10.1177/0004563215620441/asset/images/large/10.1177_0004563215620441-fig1.jpeg)
Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016
![Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012250-fx1.jpg)
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
![Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table2-1.png)
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2009.151/MediaObjects/41581_2009_Article_BFnrneph2009151_Fig1_HTML.jpg)
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
![Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report](https://www.spandidos-publications.com/article_images/ol/12/3/ol-12-03-1884-g02.jpg)
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
![SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain](https://minio.scielo.br/documentstore/1806-0870/bmKRgcYXXQnRYh8pxk4mj5Q/5bd873428955d5251700c948e7a67ec7a186cd92.jpg)
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
![JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma](https://pub.mdpi-res.com/jpm/jpm-13-00743/article_deploy/html/images/jpm-13-00743-g001.png?1682574067)